Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 111.16B P/E 17.58 EPS this Y 12.50% Ern Qtrly Grth 12.90%
Income 6.24B Forward P/E 12.74 EPS next Y 11.60% 50D Avg Chg 4.00%
Sales 171.75B PEG 1.19 EPS past 5Y 12.97% 200D Avg Chg -2.00%
Dividend 1.00% Price/Book 2.91 EPS next 5Y 12.10% 52W High Chg -14.00%
Recommedations 1.80 Quick Ratio 1.22 Shares Outstanding 232.42M 52W Low Chg 14.00%
Insider Own 0.20% ROA 5.78% Shares Float 231.81M Beta 0.79
Inst Own 92.10% ROE 15.96% Shares Shorted/Prior 1.94M/2.34M Price 471.72
Gross Margin 27.75% Profit Margin 3.64% Avg. Volume 1,369,872 Target Price 605.45
Oper. Margin 7.53% Earnings Date Jul 17 Volume 932,969 Change 0.80%
About Elevance Health, Inc.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Elevance Health, Inc. News
05/10/24 Here's Why Elevance Health (ELV) is a Strong Growth Stock
05/10/24 Elevance Health, Inc.'s (NYSE:ELV) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
05/09/24 Here's Why Elevance Health (ELV) is a Strong Value Stock
05/09/24 AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
05/06/24 Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
05/02/24 The Return Trends At Elevance Health (NYSE:ELV) Look Promising
05/01/24 Is Elevance Health (ELV) a Buy as Wall Street Analysts Look Optimistic?
05/01/24 If You Invested $1000 in Elevance Health a Decade Ago, This is How Much It'd Be Worth Now
04/27/24 Investing in Elevance Health (NYSE:ELV) five years ago would have delivered you a 118% gain
04/26/24 HCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions
04/26/24 Here's Why Elevance Health (ELV) is a Strong Momentum Stock
04/26/24 Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
04/26/24 Elevance Health Inc EVP & President, Gov Health Felicia Norwood Sells 20,310 Shares
04/25/24 Community Health (CYH) Q1 Earnings Top on Better Occupancy Rates
04/25/24 Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership
04/25/24 Universal Health (UHS) Q1 Earnings Beat on Rising Patient Days
04/25/24 All You Need to Know About Elevance Health (ELV) Rating Upgrade to Buy
04/25/24 ELV or AVTR: Which Is the Better Value Stock Right Now?
04/25/24 3 Medical Services Industry Stocks to Buy as Nursing Market Booms
04/25/24 Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?
ELV Chatroom

User Image Benzinga Posted - 2 days ago

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet https://www.benzinga.com/general/health-care/24/05/38763450/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet $ELV

User Image StockInvest_us Posted - 2 days ago

Signal alert: $ELV - Overbought Trend Short (Overvalued) https://stockinvest.us/l/VogC5nccsi

User Image crtlabz Posted - 2 days ago

$ELV and, another bute!

User Image StockInvest_us Posted - 1 week ago

Signal alert: $ELV - GoldenStar https://stockinvest.us/l/muU6Ua14dd

User Image contangoz Posted - 04/30/24

ARGUS tgt to 600 $elv

User Image StockInvest_us Posted - 04/29/24

Signal alert: $ELV - Overbought Trend Short (Overvalued) https://stockinvest.us/l/FpsHzRJp2N

User Image MyStocksZoom Posted - 04/29/24

$CANOQ $HUM wants to keep the right of first refusal (ROFR). Might have a last minute bidding war with $ELV now that Cano is cash flow positive starting August 2024. Hopefully a sale above $4 billion.

User Image QuiverQuant Posted - 04/26/24

CONGRESSIONAL TRADING: Representative Dan Newhouse disclosed a purchase of $1,001 - $15,000 of $ELV on 2024-04-25.

User Image insiderbuyingselling Posted - 04/25/24

$ELV new insider selling: 20310 shares. http://insiderbuyingselling.com/?t=ELV

User Image MyStocksZoom Posted - 04/25/24

$CANOQ Plans to have around 80 centers. Looks like a good fit for the $4bn investment plan of $ELV to partner with Clayton, Dubilier & Rice. Tampa centers will be shut down to maximize Cano's profit margin and the members will be transferred to Millennium Physician Group. This strategic partnership will capture a lot Florida's medicare market which is a prime destination for retirees.

User Image thayford Posted - 04/25/24

Breakout watch $ELV and $CASY

User Image thayford Posted - 04/25/24

$ELV $MRK $OSCR $XLV Signs of a healthy market despite all the drama over the last couple weeks. SPY

User Image thayford Posted - 04/25/24

@osubuckeye my rotation into $XLV sector in the first week of April has been working out beautifully.. $OSCR, $MRK, $ELV

User Image crtlabz Posted - 04/25/24

$ELV

User Image kagrawala Posted - 04/24/24

$HUM i am so thankful i did not fall for the HUM bandwagon- their management is truly awful. Long $unh & $elv

User Image Nosh Posted - 04/23/24

$UNH $HUM Locked in some profits on these two...will look lower or go into $ELV on a pullback.

User Image crtlabz Posted - 04/23/24

$ELV

User Image hodllow Posted - 04/19/24

$ELV

User Image hodllow Posted - 04/19/24

$ELV 2 large inverted hammer candles on the daily. Extremely bearish, this could see a significant price drop

User Image THE_TRADE Posted - 04/19/24

$CVS $UNH $HUM $ELV CVS earnings report should be juicy like their dividend 🐂

User Image Simon77 Posted - 04/19/24

$CVS cheapest defensive piece to play. Pile in. Have rallied with the rest $UNH $HUM $ELV

User Image DonCorleone77 Posted - 04/19/24

$ELV Elevance Health price target raised to $621 from $584 at Barclays Barclays analyst Andrew Mok raised the firm's price target on Elevance Health to $621 from $584 and keeps an Overweight rating on the shares post the Q1 report. The analyst remains positive on Elevance following its "positively differentiated" cost trend, solid execution in Carelon, and "guarded optimism" in Medicare.

User Image mikesterz7 Posted - 04/18/24

$ELV Elevance Health Inc. reported Q1 EPS of $10.64, $0.16 better than the analyst estimate of $10.48. Revenue for the quarter came in at $42.3 billion versus the consensus estimate of $42.47 billion. GUIDANCE: Elevance Health Inc. sees FY2024 EPS at greater of $37.20, versus the consensus of $37.15.

User Image crtlabz Posted - 04/18/24

$ELV

User Image Elev8edTrader Posted - 04/18/24

$ELV Elevance Health Shares Rise After Q1 Results Top Estimates, Analysts Boost Price Targets

User Image ryohwang Posted - 04/18/24

$ELV back to 520, the ER is ok nothing good nothing bad but the sp already at recent high

User Image kagrawala Posted - 04/18/24

$UNH $ELV moral of the story - make outsized bets based on fact - not just herd mentality. Everyone was not seeing the forest though the trees.

User Image cubie Posted - 04/18/24

@lukenight @simon58 @jargv @jenbunn @randydeansr @keywestave01 @TraderRapp @ykante @kindness123 @CVT318 and sector rule😏😅 $elv also peaked (temporarily at least) 14 minutes ago and pullback $5, $unh just did same, can't make this sht up Simon

User Image cubie Posted - 04/18/24

@jenbunn @simon58 @jargv @randydeansr @keywestave01 @ykante @TraderRapp @kindness123 @lukenight @CVT318 fudge should've strangled $unh for $elv earnings 😢😭

User Image MyStocksZoom Posted - 04/18/24

$CANOQ Member engagement team being trained by $ELV. Looks like a takeover in the works. Don't mind if $UNH crash the party and start a bidding war.

Analyst Ratings
Mizuho Buy Apr 24, 24
RBC Capital Outperform Apr 19, 24
UBS Buy Apr 19, 24
Wells Fargo Overweight Apr 19, 24
Truist Securities Buy Apr 19, 24
Jefferies Buy Apr 19, 24
Barclays Overweight Apr 19, 24
Cantor Fitzgerald Overweight Apr 10, 24
Wells Fargo Overweight Apr 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dixon Robert L JR Director Director Jul 21 Sell 476.71 310 147,780 9,638 07/21/23
Kendrick Charles Morgan JR EVP & President, Com.. EVP & President, Commercial Jun 09 Option 280.62 6,328 1,775,763 20,857 06/13/22
Kendrick Charles Morgan JR EVP & President, Com.. EVP & President, Commercial Jun 09 Sell 489.56 6,328 3,097,936 14,529 06/13/22
PERU RAMIRO G Director Director May 18 Sell 468.88 990 464,191 9,405 05/20/22
Haytaian Peter D EVP & Pres., DBG & I.. EVP & Pres., DBG & IngenioRx Mar 10 Option 131.8 1,848 243,566 29,864 03/14/22
Haytaian Peter D EVP & Pres., DBG & I.. EVP & Pres., DBG & IngenioRx Mar 10 Sell 461.16 17,703 8,163,915 12,161 03/14/22
Penczek Ronald W CAO & Controller CAO & Controller Mar 01 Option 296.81 1,559 462,727 4,325 03/03/22
Penczek Ronald W CAO & Controller CAO & Controller Mar 01 Sell 463.68 2,423 1,123,497 1,902 03/03/22
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Dec 17 Option 146.93 5,833 857,043 38,475 12/17/20
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Dec 17 Sell 312.73 5,833 1,824,154 32,642 12/17/20
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Nov 18 Option 123.85 1,708 211,536 38,476 11/18/20
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Nov 18 Sell 333.9 5,834 1,947,973 32,642 11/18/20
ZIELINSKI THOMAS C EVP & General Counse.. EVP & General Counsel Nov 04 Option 232.04 1,893 439,252 19,803 11/04/20
ZIELINSKI THOMAS C EVP & General Counse.. EVP & General Counsel Nov 04 Sell 292.35 9,175 2,682,311 17,910 11/04/20